Mizuho Maintains Buy on Edwards Lifesciences, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Anthony Petrone has maintained a Buy rating on Edwards Lifesciences (NYSE:EW) and increased the price target from $85 to $95.

February 07, 2024 | 1:43 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho analyst Anthony Petrone reaffirmed a Buy rating on Edwards Lifesciences and raised the price target from $85 to $95.
The increase in price target by Mizuho reflects a positive outlook on Edwards Lifesciences, likely due to strong performance or favorable market conditions. This endorsement from a reputable analyst could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100